ROCHE FINANCE LTD 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:49 pm Unchanged |
2022-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
ROCHE FINANCE LTD | 462,461 4.200% |
0 (Unchanged) |
Filing |
| 2021-10-04 08:54 am Purchase |
2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR |
ROCHE FINANCE LTD | 462,461 12.700% |
462,461 (New Position) |
Filing |